Sales rise 43.14% to Rs 4.28 crore
Net profit of Earum Pharmaceuticals reported to Rs 0.36 crore in the quarter ended June 2022 as against net loss of Rs 3.74 crore during the previous quarter ended June 2021. Sales rose 43.14% to Rs 4.28 crore in the quarter ended June 2022 as against Rs 2.99 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales4.282.99 43 OPM %-11.45-113.38 -PBDT0.38-3.38 LP PBT0.36-3.41 LP NP0.36-3.74 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
